Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot trial of bedaquiline monotherapy for multibacillary leprosy in Mali
PACTR202408643515316Phase 2Completed
- Sponsor
- Fondation Raoul Follereau
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bedaquiline in leprosy (HD), sponsored by Fondation Raoul Follereau. Primary endpoint: Safety and tolerability of bedaquiline during 8 weeks of monotherapy. Started Sep 2018; status: completed.
02
Drugs
bedaquiline
03
Conditions
leprosy (HD)
Beyond the preview
Go deeper on PACTR202408643515316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202408643515316.